stocks logo

SMMT Financial Analysis

Summit Therapeutics Inc
$
17.360
-1.550(-8.200%)

SMMT Financial Analysis

FY2024Q4FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Valuation ratios
PE
0.00
0.00
0.00
10.90
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PS
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
4.04K
8315.94%
788.21
525.61%
813.29
493.21%
138.23
-44.62%
48.05
-95.00%
125.99
-78.72%
137.10
-63.92%
249.59
961.66
592.03
379.96
0.00
0.00
0.00
PB
33.86
43.66%
36.86
180.73%
28.96
97.81%
65.74
618.47%
23.57
232.91%
13.13
629.44%
14.64
666.49%
9.15
145.31%
7.08
123.34%
1.80
-62.34%
1.91
-68.59%
3.73
-50.66%
3.17
-35.04%
4.78
-23.76%
6.08
58.33%
7.56
4.88
6.27
3.84
0.00
Dividend Yield- %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
FCF Yield- %
-1.11
-76.68%
-0.73
-87.15%
-1.78
-65.44%
-3.24
-67.76%
-4.76
-35.33%
-5.68
-86.76%
-5.15
-92.95%
-10.05
-66.96%
-7.36
-74.96%
-42.91
160.69%
-73.00
566.67%
-30.42
-29.39
97.91%
-16.46
-10.95
0.00
-14.85
0.00
0.00
0.00
PEG
0.00
0.00
0.00
0.09
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profitability Ratios
Gross Profit Margin - %
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
100.00
0.00%
100.00
0.00%
100.00
0.00%
100.00
0.00%
100.00
0.00%
100.00
0.00%
100.00
0.00%
100.00
0.00%
100.00
100.00
100.00
100.00
EBITDA Margin - %
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-9.49K
-18.53%
-8.12K
362.60%
-5.60K
-88.42%
-9.41K
-10.81%
-11.64K
38.50%
-1.75K
-82.60%
-48.40K
368.17%
-10.56K
217.67%
-8.41K
-10.08K
-10.34K
-3.32K
Operating Margin - %
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-9.67K
-17.91%
-8.26K
363.82%
-5.75K
-88.28%
-9.54K
-11.08%
-11.77K
36.05%
-1.78K
-82.72%
-49.01K
364.57%
-10.73K
213.09%
-8.66K
-10.30K
-10.55K
-3.43K
FCF Margin - %
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-20.82K
493.65%
-7.92K
106.62%
-5.99K
48.57%
-5.93K
44.37%
-3.51K
-66.68%
-3.83K
-4.03K
-28.60%
-4.11K
-10.53K
51.59%
0.00
-5.64K
0.00
-6.95K
0.00
Net Margin - %
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-11.17K
3.50%
-9.72K
549.22%
-7.14K
-83.34%
-8.56K
-6.03%
-10.80K
48.59%
-1.50K
-84.73%
-42.84K
376.60%
-9.11K
381.11%
-7.27K
-9.80K
-8.99K
-1.89K
Financial Health Ratios
Current Ratio
10.15
9.14%
8.31
361.67%
2.35
-87.68%
6.97
-50.98%
9.30
-45.07%
1.80
-78.10%
19.07
264.63%
14.22
224.66%
16.93
345.53%
8.22
83.07%
5.23
-5.77%
4.38
156.14%
3.80
-13.83%
4.49
57.54%
5.55
31.83%
1.71
4.41
2.85
4.21
0.00
Debt to Equity
0.00
-100.00%
5.59
-94.44%
51.26
-38.69%
226.19
201.91%
128.71
-68.30%
100.62
83.61
69.53%
74.92
92.60%
406.07
0.00
49.32
38.90
-54.42%
0.00
0.00
0.00
85.34
0.00
0.00
0.00
0.00
Interest Coverage Ratio
-7.31K
58126.27%
-23.67
210.22%
-14.43
130.51%
-13.65
575.74%
-12.56
294.97%
-7.63
-94.88%
-6.26
-88.09%
-2.02
-98.71%
-3.18
-99.13%
-148.89
-58.55%
-52.54
-62.38%
-156.93
-79.43%
-364.88
50.81%
-359.19
-139.67
-763.04
-241.95
0.00
0.00
0.00
Efficiency Ratios
ROE
-94.90
-84.23%
-73.21
-85.75%
-102.77
-85.31%
-130.59
-78.46%
-601.85
701.93%
-513.78
598.26%
-699.42
603.57%
-606.16
322.00%
-75.05
-31.08%
-73.58
-31.78%
-99.41
16.39%
-143.64
-108.89
-107.85
-85.41
0.00
0.00
0.00
0.00
0.00
ROA
-69.32
-51.12%
-54.53
-82.95%
-55.83
-84.44%
-53.76
-83.36%
-141.83
600.05%
-319.74
423.99%
-358.89
410.08%
-323.00
349.11%
-20.26
-75.32%
-61.02
-24.56%
-70.36
4.05%
-71.92
-82.09
-80.89
-67.62
0.00
0.00
0.00
0.00
0.00
Average Receivables Collection Days
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
15.79K
584.36%
8.31K
180.68%
6.04K
118.39%
4.87K
90.55%
2.31K
-62.63%
2.96K
2.77K
2.56K
6.17K
0.00
0.00
0.00
0.00
0.00
Accounts Receivable Turnover
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.02
-87.50%
0.04
-66.67%
0.06
-53.85%
0.08
-42.86%
0.16
166.67%
0.12
0.13
0.14
0.06
0.00
0.00
0.00
0.00
0.00
R&D % of Revenue
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
7.38K
-19.88%
7.75K
408.66%
3.83K
-90.87%
8.22K
-14.10%
9.21K
38.52%
1.52K
-79.91%
41.97K
425.71%
9.57K
140.20%
6.65K
7.58K
7.98K
3.99K
Growth Ratio
Total Revenue, YoY % Chg
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-100.00
20.21%
-100.00
-132.02%
-100.00
-431.02%
-100.00
-380.27%
-83.19
-113.35%
312.28
-569.81%
30.21
-174.15%
35.68
-92.17%
623.20
-66.47
-547.31%
-40.74
455.77
0.00
14.86
0.00
EBITDA, YoY % Chg
-80.97
-58.51%
-180.31
1021.33%
-184.86
859.31%
-155.08
-633.10%
-195.14
-437.32%
-16.08
-172.27%
-19.27
-136.87%
29.09
-280.35%
57.85
-165.81%
22.25
-186.01%
52.26
-191.72%
-16.13
-81.72%
-87.91
-6.13%
-25.87
-56.98
-57.29%
-88.25
-93.65
0.00
-133.42
0.00
EPS, YoY % Chg
-59.16
-224.31%
-153.97
-295.34%
-304.46
-448.07%
95.68
-117.17%
47.59
-25.73%
78.82
177.24%
87.47
133.13%
-557.36
16687.95%
64.08
-211.66%
28.43
19.45%
37.52
-302.59%
-3.32
-97.47%
-57.39
19.54%
23.80
-18.52
28.52%
-131.38
-48.01
0.00
-14.41
0.00

SMMT FAQs

What is SMMT's PE Ratio in 2025/3/31?

SMMT's PE ratio in March 31, 2025 is -62.23. This indicates the price investors are willing to pay for $1 of earnings.

What is SMMT's PS Ratio in 2025/3/31?

What is SMMT's Dividend Yield in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is SMMT earnings result positive or negative?How should I trade on SMMT earnings?